Accounting Estimate That the Impact of COVID-19 Would Largely Recover Within Approximately One Year
First written in FY2021-Q1. 6 of 12 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2026: 5 of 23 companies on the "Worse" side.
- FY2025Deferred tax assets increased by ¥447.499 millionAnnual report
「The main factors were increases of ¥447.499 million in deferred tax assets and ¥50.000 million in long-term deposits.」
The company disclosed that the main reason for the increase in fixed assets at the end of the current fiscal year was a ¥447.499 million increase in deferred tax assets. - FY2025-H1Deferred tax assets recognized based on tax losses arising from the discontinuation of Takewaka’s bankruptcy proceedingsAnnual report
「Regarding the decision to discontinue the bankruptcy proceedings of 株式会社竹若, which was described under "Significant Subsequent Events" in the quarterly securities report for the first quarter of the current consolidated fiscal year, tax loss carryforwards will arise during the current fiscal year. We recorded deferred tax assets after determining that they would be recoverable from the next fiscal year onward.」
Deferred tax assets have been recorded after assessing the recoverability from the next fiscal year onward of tax loss carryforwards arising in connection with the discontinuation of 竹若's bankruptcy proceedings. - FY2024Accounting estimates changed to reflect the reduced impact of infectious diseaseAnnual report
「In light of the current reduced impact of COVID-19 on our results, as well as the Group's results for the current consolidated fiscal year, we reviewed the classification set out in Implementation Guidance No. 26, Application Guidance on the Recoverability of Deferred Tax Assets.」
In light of the reduced impact of the infectious disease on results, the classification of the recoverability of deferred tax assets was reviewed, reducing the valuation allowance and other amounts by ¥50.008 million. - FY2023RestatedAnnual report
「Although the emergence of a ninth wave remains a concern, we have prepared accounting estimates for impairment losses on fixed assets, the recoverability of deferred tax assets and other matters on the assumption that the spread of the infectious disease will gradually subside.」
While expressing concern about a ninth wave, accounting estimates continue to be prepared using the assumption that the spread of the infectious disease will gradually subside. - FY2023-Q2RestatedAnnual report
「Although it is difficult to accurately predict when the infectious disease will end, we have prepared accounting estimates for impairment losses on fixed assets, the recoverability of deferred tax assets and other matters on the assumption that vaccination will become widespread and its spread will gradually subside.」
While stating that it is impossible to accurately predict when the infectious disease will end, accounting estimates continue to be prepared on the assumption that vaccination will become widespread and the spread will gradually subside. - FY2023-Q1RestatedAnnual report
「Although it is difficult to accurately predict when the infectious disease will end, we have prepared accounting estimates for impairment losses on fixed assets, the recoverability of deferred tax assets and other matters on the assumption that vaccination will become widespread and its spread will gradually subside.」
While stating that it is difficult to accurately predict when the infectious disease will end, accounting estimates continue to be prepared on the assumption that vaccination will become widespread and the spread will gradually subside. - FY2022RestatedAnnual report
「Although it is difficult to accurately predict when the infectious disease will end, with third-round vaccinations having begun, we have prepared accounting estimates for impairment losses on fixed assets, the recoverability of deferred tax assets and other matters on the assumption that its spread will gradually subside.」
While stating that it is difficult to predict when the infectious disease will end, accounting estimates use the assumption that its spread will gradually subside, following the third round of vaccinations. - FY2022-Q2RestatedAnnual report
「Although it is difficult to accurately predict when the infectious disease will end, with vaccination having begun, we have prepared accounting estimates for impairment losses on fixed assets, the recoverability of deferred tax assets and other matters on the assumption that its spread will gradually subside.」
While stating that it is difficult to accurately predict when the infectious disease will end, accounting estimates continue to be prepared on the assumption that vaccination will become widespread and the spread of the infectious disease will gradually subside. - FY2022-Q1RestatedAnnual report
「Although it is difficult to accurately predict when the infectious disease will end, with vaccination having begun, we have prepared accounting estimates for impairment losses on fixed assets, the recoverability of deferred tax assets and other matters on the assumption that its spread will gradually subside.」
Following the start of vaccination, accounting estimates continue to be prepared using the assumption that the spread of the infectious disease will gradually subside. - FY2021Assumption updated to a gradual easing of the pandemic following the start of vaccinationAnnual report
「With vaccination having begun, we have prepared accounting estimates for impairment losses on fixed assets, the recoverability of deferred tax assets and other matters on the assumption that the spread of the infectious disease will gradually subside.」
The previous explanation assumed that the impact of the infectious disease would continue from the current fiscal year onward. Following the start of vaccination, this has been updated to assume that the spread of the infectious disease will gradually subside. - FY2021-Q3Assumption changed to reflect the continued impact of infectious diseaseAnnual report
「Although we assume that the impact of COVID-19 on the Group's business will gradually recover through vaccination and other measures, we have prepared accounting estimates on the assumption that the situation will continue from the current fiscal year onward.」
Accounting estimates are being prepared on the assumption that the impact of the infectious disease will continue from the current fiscal year onward, while allowing for gradual recovery through vaccination, rather than under the previous assumption that it would generally recover within approximately one year. - FY2021-Q1First statedAnnual report
「Accounting estimates have been prepared based on the assumption that the impact of COVID-19 on the Group's business will generally recover within approximately one year, although the impact and its extent vary by store location and other factors.」
Accounting estimates for impairment of fixed assets, the recoverability of deferred tax assets and other matters have been prepared based on the assumption that the impact of the infectious disease on the business will generally recover within approximately one year.